§ Funding Round
Series A funding round for Ascend Gene & Cell Therapies raising $66M in May 2023
Series A funding round for Ascend Gene & Cell Therapies raising $66M in May 2023
| Investor | Firm Type | Partner |
|---|---|---|
AbingworthLEAD | Organization | — |
| Angel | ed mathers | |
| Organization | — | |
| Angel | andrew kozlov | |
| Organization | — | |
| Angel | jia-yi har | |
| Angel | eric shiozaki | |
| Organization | — | |
| Organization | — | |
michael beechamLEAD | Angel | michael beecham |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$66M
Top Valuation
-
Ascend Gene & Cell Therapies raised $66M in a Series A round.
The round was announced on 05/01/23.
The round was led by Abingworth, michael beecham.
